Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dan-chi-liu-wei
- Development stage
- Unknown
- Lead developer
- China Medical University Hospital
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Dan-Chi-Liu-Wei is a Traditional Chinese Medicine (TCM) herbal formula composed of the "Liu Wei Di Huang Wan" (Six-Ingredient Rehmannia Pill) base supplemented with Moutan Cortex (Dan Pi) and Gardeniae Fructus (Zhi Zi). It is primarily investigated as an adjunctive therapy for patients with systemic lupus erythematosus (SLE) who are undergoing conventional treatment with glucocorticoids and immunomodulators. The formula is intended to help stabilize disease activity and potentially facilitate the tapering of steroid dosages. Clinical research indicates that the combination is generally safe and may have a borderline effect on reducing the SLE Disease Activity Index (SLEDAI) score without adversely affecting liver or renal function, although further large-scale trials are required to confirm its efficacy in steroid tapering.
- Other names
- Dan-Chi-Liu-Wei combinationDan Zhi Di Huang WanDan-Chi-Liu-Wei-Wan
Beyond the preview
Go deeper on dan-chi-liu-wei.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dan-chi-liu-wei.